
The Food and Drug Administration (FDA) on Thursday lifted restrictions on the abortion drug, mifepristone, allowing the drugs to be prescribed online and sent by mail. The FDA announced that it was removing the "in-person dispensing requirement" that had required mifepristone to be dispensed only in certain health care facilities.
Archbishop William Lori, chairman of the U.S. Conference of Catholic Bishops' Committee on Pro-Life Activities, criticized the move, stating that the decision would continue the taking of unborn lives while doing little for the well-being of women in need. "Far from the accompaniment that women in crisis pregnancies deserve, this decision would leave women alone in the midst of trauma, often without any medical attention or follow up care", stated Archbishop Lori. He further called on government leaders to "stand with women in need by promoting policies that recognize the value and human dignity of both mother and child, rather than further promoting the devastating tragedy of abortion."